Integriculture Inc. signs a joint research contract with Tokyo Women’s Medical University on cellular agriculture.
Integriculture Inc., a biotechnology and food company aiming to reform modern agriculture through clean meat, has signed a joint research contract with Tokyo Women’s Medical University under the title of “Prototyping and demonstration of an automated cell culture system based on intercellular interactions and stimulation of cell growth.
The low-cost animal-free culture media developed through this joint research is expected to reduce the prohibitively high cost of cell culture. Reduced cell culture costs have significant positive impact on regenerative medicine and cellular agriculture by making the products affordable and saving the time for commercialization.
For details, please refer to the following announcement.
Cellular agriculture is an interdisciplinary branch of science at the intersection of medicine and farming. Cellular agriculture capitalizes on breakthroughs in tissue-engineering, material sciences, bioengineering, and synthetic biology to design new ways of producing existing agricultural products. Clean meat production by cell culture is one of the applications of cellular agriculture.
Integriculture Inc. develops low-cost large scale cell culture system that enables industrial cellular agriculture such as clean meat production.
Clean meat production used to cost more than $1,000,000/kg in 2013, but food grade animal-free culture medium and continuous flow based cell culture system developed at Integriculture Inc. has driven the cost down to ~$300/kg equivalent in laboratory scale.